Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 1,104 INR
Change Today +22.85 / 2.11%
Volume 75.3K
As of 3:02 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

emami ltd (HMN) Snapshot

Open
1,085
Previous Close
1,081
Day High
1,110
Day Low
1,081
52 Week High
03/13/15 - 1,143
52 Week Low
06/6/14 - 446.40
Market Cap
250.6B
Average Volume 10 Days
215.2K
EPS TTM
21.40
Shares Outstanding
227.0M
EX-Date
--
P/E TM
51.6x
Dividend
3.00
Dividend Yield
0.72%
Current Stock Chart for EMAMI LTD (HMN)

Related News

No related news articles were found.

emami ltd (HMN) Related Businessweek News

No Related Businessweek News Found

emami ltd (HMN) Details

Emami Limited manufactures and markets personal and health care products in India and internationally. It provides Himani Navratna and Navratna Extra Thanda cool oils; Boroplus advanced moisturising lotion; BoroPlus prickly heat powder; Mentho Plus Balm; Zandu Vigorex that enhances stamina and energy for a healthy and happy life; Zandu Sona Chandi Chyawanprash Plus; 7 Oils in One- damage control hair oils; Zandu Kesari Jivan; BoroPlus anti pollution daily face wash products; Zandu Balm; BoroPlus anti-septic creams; Zandu Pancharishta, an ayurvedic digestive tonic that acts on the entire digestive system, builds digestive immunity, and reduces the reoccurrence of digestive problems; Fast Relief, a pain relief ointment; Navratna Cool Talc; and Fair and Handsome, a fairness cream for men. The company was founded in 1974 and is based in Kolkata, India.

Founded in 1974

emami ltd (HMN) Top Compensated Officers

Managing Director, Executive Director, Chairm...
Total Annual Compensation: 7.2M
Founder, Whole Time Director, Chairman of Fin...
Total Annual Compensation: 21.0M
Founder and Executive Chairman
Total Annual Compensation: 21.0M
Wholetime Director, Chairman of Share Transfe...
Total Annual Compensation: 5.4M
Wholetime Director, Member of Share Transfer ...
Total Annual Compensation: 5.4M
Compensation as of Fiscal Year 2014.

emami ltd (HMN) Key Developments

Emami In Talks To Acquire Kesh King; Emami Denies

Emami Limited (BSE:531162) is in advance talks to acquire Kesh King brand from SBS Biotech Limited for INR 18 billion as per sources. The Exchange had sought clarification from Emami with respect to news item. The Company has clarified that "The news item has appeared on ET NOW without our knowledge and concurrence. Further, there has not been any event which requires intimation to the Stock Exchange under clause 36 of the Listing Agreement."

Emami Limited Recommends Final Dividend

Emami Ltd. has announced that the Board of Directors of the company at its meeting held on May 13, 2015, has recommended a final dividend of 300% on equity shares INR 3 per equity share of INR 1 each, subject to the approval of the shareholders in the ensuing Annual General Meeting.

Emami Limited Announces Audited Standalone and Consolidated Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Emami Limited announced audited standalone and consolidated earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, on a standalone basis, the company reported net sales/income from operations of INR 4,957.4 million compared to INR 4,101.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,171.8 million compared to INR 990.5 million a year ago. Profit from ordinary activities before tax was INR 1,462.9 million compared to INR 1,112.4 million a year ago. Net profit was INR 1,323.4 million compared to INR 1,151.9 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 5.83 compared to INR 5.08 a year ago. For the year, on a standalone basis, the company reported net sales/income from operations of INR 20,306.4 million compared to INR 17,050.8 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 4,787.3 million compared to INR 3,943.9 million a year ago. Profit from ordinary activities before tax was INR 5,769.8 million compared to INR 4,517.9 million a year ago. Net profit was INR 4,716.3 million compared to INR 3,982.3 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 20.78 compared to INR 17.55 a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations of INR 5,536.6 million compared to INR 4,457.1 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,292.6 million compared to INR 1,005.0 million a year ago. Profit from ordinary activities before tax was INR 1,516.4 million compared to INR 1,075.9 million a year ago. Net profit was INR 1,381.9 million compared to INR 1,111.3 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 6.09 compared to INR 4.90 a year ago. EBIDTA grew by 18.9% at INR 1,400 million. The growth in the fourth quarter of 2015 was achieved by the strong performance of domestic business that registered a handsome topline growth of 20.5%. For the year, on consolidated basis, the company reported net sales/income from operations of INR 22,172.5 million compared to INR 18,207.7 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 5,057.7 million compared to INR 4,061.3 million a year ago. Profit from ordinary activities before tax was INR 5,924.5 million compared to INR 4,571.3 million a year ago. Net profit was INR 4,874.5 million compared to INR 4,024.3 million a year ago. Basic and diluted EPS before and after extraordinary items was INR 21.40 compared to INR 17.73 a year ago. EBIDTA at INR 5,400 million grew by 22.4%.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HMN:IN 1,104.00 INR +22.85

HMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dabur India Ltd 266.60 INR -2.75
Godrej Consumer Products Ltd 1,097 INR -36.55
Jyothy Laboratories Ltd 263.00 INR +0.55
Kose Corp ¥8,230 JPY 0.00
Marico Ltd 409.25 INR -2.05
View Industry Companies
 

Industry Analysis

HMN

Industry Average

Valuation HMN Industry Range
Price/Earnings 49.0x
Price/Sales 10.7x
Price/Book 19.4x
Price/Cash Flow 45.8x
TEV/Sales 10.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EMAMI LTD, please visit www.emamiltd.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.